Clostridium perfringens liver abscess with massive haemolysis

Hong Kong Medical Journal

Volumn 16, Issue 4, 2010, Pages 310-312

  Ng, H ^a   Lam, S M ^a   Shum, H P ^a   Yan, W W ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Anemia; Clostridium infections; Clostridium perfringens; Hemolytic; Liver abscess; Treatment outcome

Indexed keywords

AMPICILLIN; CEFUROXIME; HEMOGLOBIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ABSCESS DRAINAGE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BILIARY TRACT INFECTION; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS INFECTION; CONTINUOUS HEMOFILTRATION; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAVASCULAR HEMOLYSIS; LAPAROTOMY; LIVER ABSCESS; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; NONHUMAN; PLESIOMONAS SHIGELLOIDES; SEPTIC SHOCK; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; FEMALE; HUMANS; LIVER ABSCESS; MIDDLE AGED; MULTIPLE ORGAN FAILURE;

EID: 77957733716     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lok KH, Li KF, Li KK, Szeto ML. Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol Infect 2008;41:483-490.
2. Chou FF, Sheen-Chen SM, Chen YS, Lee TY. The comparison of clinical course and results of treatment between gas-forming and non-gas-forming pyogenic liver abscess. Arch Surg 1995;130:401-405.
3. Kreidl KO, Green GR, Wren SM. Intravascular hemolysis from a Clostridium perfringens liver abscess. J Am Coll Surg 2002;194:387.
4. Rood JI, Cole ST. Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev 1991;55:621-648.
5. Bätge B, Filejski W, Kurowski V, Klüter H, Djonlagic H. Clostridial sepsis with massive intravascular hemolysis: rapid diagnosis and successful treatment. Intensive Care Med 1992;18:488-490.
6. Kapoor JR, Monteiro B, Tanoue L, Siegel MD. Massive intravascular hemolysis and a rapidly fatal outcome. Chest 2007;132:2016-2019.
7. Ohtani S, Watanabe N, Kawata M, Harada K, Himei M, Murakami K. Massive intravascular hemolysis in a patient infected by a Clostridium perfringens. Acta Med Okayama 2006;60:357-360.
8. Au WY, Lau LS. Massive haemolysis because of Clostridium perfringens liver abscess in a patient on peritoneal dialysis. Br J Haematol 2005;131:2. Erratum in: Br J Haematol 2006;132:805.
9. Chu KM, Fan ST, Lai EC, Lo CM, Wong J. Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg 1996;131:148-152.
10. Rogstad B, Ritland S, Lunde S, Hagen AG. Clostridium perfringens septicemia with massive hemolysis. Infection 1993;21:54-56.
11. Schwartzman JD, Reller LB, Wang WL. Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics. Antimicrob Agents Chemother 1977;11:695-697.
12. Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 1987;31:213-218.